GSK reaches $2.2bn heartburn medication Zantac settlement in US
WEB1 day ago · GSK has reached a $2.2bn settlement to resolve the vast majority of cases linked to its heartburn medicine Zantac, in a move that will help assuage legal concerns overhanging the UK drugmaker.
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 …
WEB1 day ago · (Reuters) -GSK has agreed to pay up to $2.2 billion to settle most pending U.S. state court lawsuits claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company ...
GSK to Settle 80,000 Zantac Cases for Up to $2.2 Billion
WEB1 day ago · GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to contamination of its Zantac reflux medication with a suspected carcinogen.. The cases represent ...
GSK to pay $2.2B to settle most Zantac lawsuits over claims pill
WEB2 days ago · By Ed Silverman. Oct. 9, 2024. Pharmalot Columnist, Senior Writer. After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a ...
GSK Reached Agreements With 10 Plaintiff Firms Over Zantac …
WEB1 day ago · By Cristina Gallardo. GSK agreed to pay $2.2 billion to 10 plaintiff firms over liability cases related to its discontinued heartburn medicine Zantac allegedly causing cancer. The British ...
Statement: Zantac (ranitidine) litigation – settlement ... - GSK
WEB2 days ago · 09 October 2024. Issued: London, UK. For media and investors only. Statement: Zantac (ranitidine) litigation – settlement agreements reached. Download (PDF, 130.6KB) GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac product liability cases for up to $2.2 billion. Separate settlement of qui tam complaint for …
GSK Reached Agreements With 10 Plaintiff Firms Over Zantac …
WEB1 day ago · GSK GSK 0.34% increase; green up pointing triangle agreed to pay $2.2 billion to 10 plaintiff firms over liability cases related to its discontinued heartburn medicine Zantac allegedly causing cancer.
GSK Reaches up to $2.2 Billion Settlement in Zantac US ... - U.S. News
WEB1 day ago · REUTERS/Brendan McDermid/Illustration/File Photo. (Reuters) - GSK said on Wednesday it had reached agreements with ten plaintiff firms, representing 93% of U.S. state court Zantac product ...
GSK set to face jury trials over heartburn drug Zantac - Financial Times
WEBJun 1, 2024 · GSK and other pharmaceutical groups are set to face jury trials in cases brought by more than 72,000 cancer sufferers who allege a heartburn drug caused their condition, after a judge in Delaware...
GSK knew about Zantac cancer risk, attorneys tell jury in first trial ...
WEBMay 2, 2024 · U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and...